$71.01 -0.56 (-0.78%) Gilead Sciences Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 71.01
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: -0.56 (-0.78%)
Prev Close: 71.57
Open: 71.97
Bid: 71.00
Ask: 71.01

Competitors

Ticker Name Volume % Change
SGYP Synergy Pharmaceuticals Inc. 20.05M -7.80%
RNN Rexahn Pharmaceuticals Inc. 6.76M +5.75%
IDXG PDI Inc. 6.35M -5.87%
MSTX Mast Therapeutics Inc. 4.54M +1.56%
LLY Eli Lilly and Company 4.29M -0.04%

GILD Stock Analysis

Partner Headlines

  1. Gilead Will Boost HIV, NASH Drugs Amid Hep C Slump; Stock On 2-Week Dip

    Investors Business Daily | Jan. 20, 2017 | 15:02PM EST
  2. Incyte Poised To Outperform Biotech Industry On Strong Pipeline

    Investors Business Daily | Jan. 20, 2017 | 11:00AM EST
  3. Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst

    Investors Business Daily | Jan. 19, 2017 | 16:41PM EST
  4. Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Investors Business Daily | Jan. 18, 2017 | 16:33PM EST
  5. Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target

    TalkMarkets | Jan. 9, 2017 | 07:51AM EST
  6. Widespread Buying

    TalkMarkets | Jan. 6, 2017 | 15:46PM EST